Literature DB >> 8622941

Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.

H Molina1, V M Holers, B Li, Y Fung, S Mariathasan, J Goellner, J Strauss-Schoenberger, R W Karr, D D Chaplin.   

Abstract

Complement receptor 1 (CR1, CD35) and complement receptor 2 (CR2, CD21) have been implicated as regulators of B-cell activation. We explored the role of these receptors in the development of humoral immunity by generating CR1- and CR2-deficient mice using gene-targeting techniques. These mice have normal basal levels of IgM and of IgG isotypes. B- and T-cell development are overtly normal. Nevertheless, B-cell responses to low and high doses of a T-cell-dependent antigen are impaired with decreased titers of antigen-specific IgM and IgG isotypes. This defect is not complete because there is still partial activation of B lymphocytes during the primary immune response, with generation of splenic germinal centers and a detectable, although reduced, secondary antibody response. These data suggest that certain T-dependent antigens manifest an absolute dependence on complement receptors for the initiation of a normally robust immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622941      PMCID: PMC39612          DOI: 10.1073/pnas.93.8.3357

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  The regulators of complement activation (RCA) gene cluster.

Authors:  D Hourcade; V M Holers; J P Atkinson
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 2.  The CD19/CD21 signal transduction complex of B lymphocytes.

Authors:  T F Tedder; L J Zhou; P Engel
Journal:  Immunol Today       Date:  1994-09

3.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.

Authors:  P Engel; L J Zhou; D C Ord; S Sato; B Koller; T F Tedder
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

4.  Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.

Authors:  R C Rickert; K Rajewsky; J Roes
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

5.  Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.

Authors:  T Kinoshita; J Takeda; K Hong; H Kozono; H Sakai; K Inoue
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

6.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

7.  An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies.

Authors:  B Heyman; G Holmquist; P Borwell; U Heyman
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

Review 8.  Regulation of immune response by components of the complement cascade and their activated fragments.

Authors:  W O Weigle; M G Goodman; E L Morgan; T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1983

9.  Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).

Authors:  T Kinoshita; S Lavoie; V Nussenzweig
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

10.  Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.

Authors:  Y Kozono; R C Duke; M S Schleicher; V M Holers
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

View more
  140 in total

Review 1.  The role of complement in the acquired immune response.

Authors:  C H Nielsen; E M Fischer; R G Leslie
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

2.  Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.

Authors:  H Illges; M Braun; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 4.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 5.  Role of CD19 signal transduction in B cell biology.

Authors:  Robert H Carter; Yue Wang; Stephen Brooks
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 6.  Complement-dependent transport of antigen into B cell follicles.

Authors:  Santiago F Gonzalez; Veronika Lukacs-Kornek; Michael P Kuligowski; Lisa A Pitcher; Søren E Degn; Shannon J Turley; Michael C Carroll
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

7.  CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Authors:  Keith M Woods; Michael R Pope; Sara M Hoffman; Sherry D Fleming
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 8.  Complement receptors and the shaping of the natural antibody repertoire.

Authors:  V Michael Holers
Journal:  Springer Semin Immunopathol       Date:  2004-12-22

Review 9.  Reconstructing immune phylogeny: new perspectives.

Authors:  Gary W Litman; John P Cannon; Larry J Dishaw
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

Review 10.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.